Pathophysiology and management of anemia in chronic progressive renal failure.

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Hypoproliferative anemia is a predictable and serious complication of progressive renal failure and contributes significantly to the overall morbidity of the uremic state. Until recently, there has been no satisfactory therapy to resolve the anemia. Now the anemia can be explicitly corrected with erythropoietin-replacement therapy, and the clinical debility generally attributable to renal insufficiency can be lessened and retarded. Anemia must no longer be regarded as an intractable consequence of the uremic syndrome and should be managed as conscientiously as the other polysystemic features of uremia.

Original languageEnglish (US)
Pages (from-to)175-182
Number of pages8
JournalSeminars in veterinary medicine and surgery (small animal)
Volume7
Issue number3
StatePublished - Aug 1992

Fingerprint

renal failure
pathophysiology
anemia
Chronic Kidney Failure
Anemia
Renal Insufficiency
erythropoietin
therapeutics
uremia
morbidity
Uremia
Erythropoietin
kidneys
Morbidity
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{47c53e0ae8b040c2af14221cedb6028d,
title = "Pathophysiology and management of anemia in chronic progressive renal failure.",
abstract = "Hypoproliferative anemia is a predictable and serious complication of progressive renal failure and contributes significantly to the overall morbidity of the uremic state. Until recently, there has been no satisfactory therapy to resolve the anemia. Now the anemia can be explicitly corrected with erythropoietin-replacement therapy, and the clinical debility generally attributable to renal insufficiency can be lessened and retarded. Anemia must no longer be regarded as an intractable consequence of the uremic syndrome and should be managed as conscientiously as the other polysystemic features of uremia.",
author = "Cowgill, {Larry D}",
year = "1992",
month = "8",
language = "English (US)",
volume = "7",
pages = "175--182",
journal = "Topics in Companion Animal Medicine",
issn = "1938-9736",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Pathophysiology and management of anemia in chronic progressive renal failure.

AU - Cowgill, Larry D

PY - 1992/8

Y1 - 1992/8

N2 - Hypoproliferative anemia is a predictable and serious complication of progressive renal failure and contributes significantly to the overall morbidity of the uremic state. Until recently, there has been no satisfactory therapy to resolve the anemia. Now the anemia can be explicitly corrected with erythropoietin-replacement therapy, and the clinical debility generally attributable to renal insufficiency can be lessened and retarded. Anemia must no longer be regarded as an intractable consequence of the uremic syndrome and should be managed as conscientiously as the other polysystemic features of uremia.

AB - Hypoproliferative anemia is a predictable and serious complication of progressive renal failure and contributes significantly to the overall morbidity of the uremic state. Until recently, there has been no satisfactory therapy to resolve the anemia. Now the anemia can be explicitly corrected with erythropoietin-replacement therapy, and the clinical debility generally attributable to renal insufficiency can be lessened and retarded. Anemia must no longer be regarded as an intractable consequence of the uremic syndrome and should be managed as conscientiously as the other polysystemic features of uremia.

UR - http://www.scopus.com/inward/record.url?scp=0026910546&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026910546&partnerID=8YFLogxK

M3 - Article

C2 - 1410849

AN - SCOPUS:0026910546

VL - 7

SP - 175

EP - 182

JO - Topics in Companion Animal Medicine

JF - Topics in Companion Animal Medicine

SN - 1938-9736

IS - 3

ER -